Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

TERUMO MEDICAL CORPORATION

Request full access

Technology and medical devices for hollow fiber technology, blood management systems, and endovascular therapy

Franklin Township, United StatesFounded 1972Health

About TERUMO MEDICAL CORPORATION

Terumo Corporation is a global leader in medical technology, specializing in the development and manufacturing of medical devices and equipment. The company serves healthcare providers, hospitals, and clinics worldwide, focusing on cardiovascular health, blood management, and interventional systems. Terumo operates in various markets including Japan, North America, South America, Europe, the Middle East, Africa, Greater China, and the Asia-Pacific region. Its business model revolves around the production and sale of high-quality medical devices, which generate revenue through direct sales, partnerships, and long-term contracts with healthcare institutions. Terumo's product portfolio includes drug-eluting stents, glucose monitors, vascular grafts, and endovascular devices, among others. The company is committed to sustainability and actively contributes to global health initiatives, such as COVID-19 pandemic relief efforts.

Source: Dealroom company data

At a glance

Status
Operational
Employees
2,924
Open positions
None listed
Industry
Health
Sector
Cardiology and cardiovascular
Business model
Manufacturing
Client focus
B2B
Investment activity
2 companies, latest Dec 2025
Capital deployed
$18M
Preferred round
SERIES A

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
GRANTOther financing Jun 2016 $17M — US Biomedical Advanced Research and Development Authority —
EARLY VCEquity / VC Dec 2010 $2.1M $8.4M Undisclosed —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

TERUMO MEDICAL CORPORATION website traffic

Latest recorded traffic for TERUMO MEDICAL CORPORATION is 23K monthly website visits, up 35.3% over the last three months. TERUMO MEDICAL CORPORATION's team grew 13.6% over the past year.

Latest monthly visits23K 3-month web change+35.3% 1-year team growth+13.6%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
GrownValveGrownValve created the first autologous heart valve utilizing medical imaging and 3D printing. It eliminates tissue rejection and recurring surgery hazards (bleeding, infection and death) Berlin, Germany Operational 19 $2.5M —
SpectrawaveDiagnosis and treatment of cardiovascular disease through the development of innovative optical diagnostic and therapeutic devices Waltham, United States Acquired
Cyfuse BiomedicalScaffold-free bio 3D printing for regenerative medicine Tokyo, Japan Operational
Aderis PharmaceuticalsAderis Pharmaceuticals focused on discovery, development and commercialization of products for the diagnosis Hopkinton, United States Acquired
Micell TechnologiesBiomedical device company developing interventional cardiology systems for vascular drug delivery Durham, United States Operational
ElutiaHighCape Partners and Tissue Banks International with the mission of restoring health and mobility to the greatest number of patients United States Acquired
Sadra MedicalFocused on developing minimal invasive alternatives to surgical valve replacement and improve patient care Campbell, United States Acquired
VenoStentBiomaterial platform and medical device company that has developed an external stent using shape memory polymers Houston, United States Operational
Showing 8 of the closest matchesCompare every metric →

TERUMO MEDICAL CORPORATION in the Franklin Township ecosystem

Live from Dealroom

The TERUMO MEDICAL CORPORATION office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • US Biomedical Advanced Research and Development Authority
Team profiled 35 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 8 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
47 countries with
team presence
🇺🇸 United States66%
🇧🇪 Belgium4.1%
🇲🇽 Mexico1.9%
🇵🇭 Philippines1.7%
🇨🇦 Canada1.7%
Top 5 of 47 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about TERUMO MEDICAL CORPORATION on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See TERUMO MEDICAL CORPORATION’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.